Companies: 10,795·Total market cap: $144.5T
SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

SWTXNASDAQHealthcare
$46.99
+$0.01(+0.02%)
Market Cap$3.5B
P/E Ratio—
52W High$62
52W Low$28.21
SEC Filings

SpringWorks Therapeutics, Inc. (SWTX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001773427 · SWTX · NASDAQ · as of Jun 8, 2026

Filing snapshot

461
Total Filings
SCHEDULE 13G/A
Latest Form
2025-11-12
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001773427 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-02-20
Fiscal Year End
Feb 20, 2025
Accession No.
0001773427-25-000010
Primary Document
swtx-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001773427 · Accession 0001773427-25-000010

Latest Key Filings

10-QQuarterly Report
10-Q
2025-05-09
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2025-07-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-12
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-08-13
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-08-08
View
15-12G15-12G
15-12G
2025-07-11
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-07-07
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
S-8 POSS-8 POS
S-8 POS
2025-07-01
View
POSASRPOSASR
POSASR
2025-07-01
View
25-NSE25-NSE
25-NSE
2025-07-01
View
8-KCurrent Report
FORM 8-K
2025-07-01
View
Showing 1–15 of 228 filingsForm 4 / 144 hidden· 461 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001773427  |  Exchange: NASDAQ · Healthcare

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has submitted 461 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001773427, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is SpringWorks Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent SpringWorks Therapeutics, Inc. 10-K was filed on 2025-02-20 for fiscal year ending 2025. Historical SWTX 10-K annual reports are available from 2019 through 2025.

Investors researching SpringWorks Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
MOR SEC Filings →MRTX SEC Filings →RYZB SEC Filings →CBAY SEC Filings →ONEM SEC Filings →MORF SEC Filings →KDNY SEC Filings →MYOV SEC Filings →
→ SWTX Financials→ SWTX Earnings→ SWTX Insider Trades

Frequently Asked Questions

SWTX SEC Filings · 8 questions

SpringWorks Therapeutics, Inc. (SWTX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 461 filings and access original documents at no cost. SpringWorks Therapeutics, Inc.'s CIK is 0001773427.

SWTX SEC filingsSpringWorks Therapeutics, Inc. SEC documentsfind SWTX 10-K